OakChart

TG Therapeutics Inc

TGTXHealthcare·Biotechnology·USA·Mid·NASD·Nov 11 • 3:59 PM ET

65.76+1.50 (2.33%)
2026-11-12 04:08 CET
Market cap
10,065.82 USD m
Revenue, TTM
897.76 USD m
Net income, TTM
106.06 USD m
Free cash flow, TTM
85.56 USD m
EPS diluted, TTM
0.67
P/E
97.67
Compare

Price

TGTX against its 20, 50 and 200-day averages
2050200miss
30.0040.0050.0060.0070.003.6M7.2MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TGTXclose 65.7620-day 57.9950-day 56.39200-day 45.0365.7652w high

3.3% under the 52-week high of 68.03 on 10 Nov 2026. 52-week low 26.76 on 12 Mar 2026. Last 15 sessions, 31.2% high to low

Volume 1.08× normal · the line is the 50-bar volume average

Profile

TGTX
52-week range, 94% of the way up
26.7668.03

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

IndexRUT
Employees399
IPODec 14, 1995
Beta1.80
ATR, 14d3.26
Rel volume1.08
Short float20.57%
Insider own7.47%
Inst own75.60%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap9.94B
Enterprise Value10.19B
Income106.06M
Sales897.76M
Book/sh3.78
Cash/sh3.34
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees399
IPODec 14, 1995

Ratios

P/E97.67
Forward P/E23.30
PEG2.02
P/S11.07
P/B17.37
P/C19.70
P/FCF116.17
EV/EBITDA52.61
EV/Sales11.35
Quick Ratio3.75
Current Ratio4.50
Debt/Eq1.32
LT Debt/Eq1.32
Option/ShortYes / Yes

Earnings

EPS (ttm)0.67
EPS next Y2.82
EPS next Q0.52
EPS this Y-62.66%
EPS next Y172.89%
EPS next 5Y11.54%
EPS past 3/5Y- -
Sales past 3/5Y504.86% 426.73%
EPS Y/Y TTM-75.71%
Sales Y/Y TTM68.78%
EPS Q/Q-85.35%
Sales Q/Q60.74%
EarningsNov 09 BMO
EPS/Sales Surpr.-2.59% 5.89%

Ownership

Insider Own7.47%
Insider Trans-0.04%
Inst Own75.60%
Inst Trans3.31%
ROA8.10%
ROE17.99%
ROIC8.01%
Gross Margin82.74%
Oper. Margin21.48%
Profit Margin11.81%
SMA2013.40%
SMA5016.63%
SMA20046.02%
Trades-

Technical

Shs Outstand151.16M
Shs Float139.86M
Short Float20.57%
Short Ratio15.06
Short Interest28.77M
52W High68.03 -3.34%
52W Low26.76 145.74%
Volatility8.69% 5.48%
ATR (14)3.26
RSI (14)69.78
Beta1.80
Rel Volume1.08
Avg Volume1.91M
Volume2,059,466

Performance

Perf Week6.70%
Perf Month21.02%
Perf Quarter37.17%
Perf Half Y54.19%
Perf YTD120.60%
Perf Year111.38%
Perf 3Y543.44%
Perf 5Y98.25%
Perf 10Y1074.29%
Recom1.33
Target Price69.43
Prev Close64.26
Price65.76
Change %2.33%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 06, 2025ResumedHH.C. WainwrightBuy$60-8.8%
Jul 10, 2025ResumedGGoldmanNeutral$37-43.7%
Oct 29, 2024InitiatedTTD CowenBuy$50-24.0%
Aug 02, 2023UpgradeGGoldmanSell → Neutral$16 → $12-81.8%
Jun 26, 2023ResumedJJefferiesBuy$55 → $40-39.2%
May 20, 2022InitiatedBBofA SecuritiesUnderperform$5-92.4%
Feb 23, 2022ReiteratedRB. Riley SecuritiesBuy$49 → $35-46.8%
Nov 15, 2021DowngradeGGoldmanNeutral → Sell$33 → $26-60.5%
Apr 20, 2021InitiatedGGoldmanNeutral$50-24.0%
Apr 19, 2021ReiteratedHH.C. WainwrightBuy$79 → $89+35.3%

Peers

Mkt cap
TickerCompanyMkt cap
BIIBBiogen Inc37.46B
IMUXImmunic Inc110.79M
NVSNovartis AG ADR293.47B
AXSMAxsome Therapeutics Inc7.85B
ARGXArgen X SE ADR61.48B
CTNMContineum Therapeutics Inc422.90M
ACADAcadia Pharmaceuticals Inc3.17B
CABACabaletta Bio Inc312.79M
KYTXKyverna Therapeutics Inc316.63M
SNYSanofi ADR115.43B

Insider trading

4 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Charney Laurence NDirectorSep 10 '26Sale54.965,000274,800168,640Sep 14 05:00 PM
Charney Laurence NDirectorSep 10 '26Proposed Sale54.965,000274,794Sep 10 04:46 PM
Echelard YannDirectorNov 24 '25Sale32.575,000162,850223,816Nov 25 05:31 PM
Echelard YannDirectorNov 24 '25Proposed Sale32.575,000162,850Nov 24 04:04 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
FBTFirst Trust NYSE Arca Biotechnology Index FundAUM: 3.03B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-090.3500.3590.350259.94245.478
2026Q22026-08-030.0500.3060.050240.34229.777
2026Q12026-05-060.1200.2760.124204.92200.338
2025Q42026-02-260.1400.3530.145192.57191.798
2025Q32025-11-032.4300.2192.428161.71152.118
2025Q22025-08-040.1700.2110.173141.15137.986
2025Q12025-05-050.0300.1720.031120.86117.887
2024Q42025-03-030.1500.1570.146108.19100.677
2024Q32024-11-040.0200.0300.02483.8881.708
2024Q22024-08-060.040-0.0460.04373.4765.927
2024Q12024-05-01-0.070-0.060-0.07363.4754.606
2023Q42024-02-28-0.090-0.100-0.10143.9740.068
2023Q32023-11-010.7300.0570.731165.8223.918
2023Q22023-08-01-0.340-0.252-0.33716.0717.399
2023Q12023-05-01-0.280-0.363-0.2807.803.388
2022Q42023-02-28-0.390-0.271-0.3870.081.609

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-1.960-2.004-1.9560.150.18
2020FY-2.420-2.297-2.4220.150.17
2021FY-2.630-2.561-2.6336.697.01
2022FY-1.460-1.344-1.4652.794.27
2023FY0.090-0.0130.085233.66231.08
2024FY0.1500.1460.146329321.49
2025FY2.7703.0152.770616.29615.57
2026FY-1.034--993.71
2027FY-2.823--1,344
2028FY-3.844--1,605
2029FY-4.215--1,846
2030FY-5.348--2,170

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-10870290.22266.9300
2026Q4S2026-11-09860286.5266.9300
2026Q4S2026-10-22800269.5259.6283
2026Q4S2026-10-17800269.51259.6283
2026Q4S2026-10-09840269.51259.6283
2026Q4S2026-09-26840269.8259.6283
2026Q4S2026-09-25850269.8259.6283
2026Q4S2026-09-20750267.92259.6282.39
2026Q4S2026-09-01751267.92259.6282.39
2026Q4S2026-08-06752267.92259.6282.39
2026Q4S2026-08-05752267.86259.6282
2026Q4S2026-08-03752267.89259.6282
2026Q4S2026-07-24723263.3250.9282
2026Q4S2026-07-21723263.23250.9282

Estimate history

EPS, annual-1.91-2.299-1.956-2.422-2.633-1.4650.0850.1462.770.6733
Period201720182019202020212022202320242025TTM
EPS, quarterly0.0240.1460.0310.1732.4280.1450.1240.050.356
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual0.1520.1520.1520.1526.6892.785233.662329.004616.287897.76
Period201720182019202020212022202320242025TTM
Sales, quarterly83.879108.185120.856141.148161.709192.574204.918240.335259.936
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual73.1483.871109.384140.576143.251146.385151.424155.836155.306151.16
Period201720182019202020212022202320242025MRQ
Shares, quarterly155.777155.836158.169158.025155.211155.306153.094153.078151.16
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue897.76616.29329.00233.662.796.690.150.150.15
Cost of Goods Sold Incl. D&A154.93100.7138.7714.550.780.790.370.280.09
Gross Profit742.84515.57290.24219.112.005.90-0.22-0.130.06
Selling, General and Administrative Excl. Other549.98392.25248.31198.47194.84350.67273.37170.12174.46
Research and Development236.22160.2294.2976.19125.35222.58165.90154.18159.39
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income192.86123.3241.9320.63-192.84-344.77-273.59-170.25-174.40
Interest Expense46.5926.7324.0312.6210.195.646.334.09-
Unusual Expense10.980.300.75-1.02-1.19-1.60-0.23-0.80-0.94
Net Income Before Taxes149.55107.3925.5913.06-198.34-348.10-279.38-172.87-173.48
Income Taxes43.49-339.792.210.390.000.000.000.000.00
Consolidated Net Income106.06447.1823.3812.67-198.34-348.10-279.38-172.87-173.48
Net Income From Continuing Operations106.06447.1823.3812.67-198.34-348.10-279.38-172.87-173.48
Net Income106.06447.1823.3812.67-198.34-348.10-279.38-172.87-173.48
EPS (Recurring)0.732.770.150.08-1.47-2.64-2.42-1.96-2.31
EPS (Basic, Before Extraordinaries)0.753.100.160.09-1.46-2.63-2.42-1.96-2.30
EPS (Diluted)0.672.770.150.09-1.46-2.63-2.42-1.96-2.30
EBITDA193.66125.3242.2121.06-192.32-344.28-273.22-169.97-174.31
Non-Operating Income (Expense)14.2611.098.454.033.500.710.310.67-0.02
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense69.6651.0933.6137.9319.1861.2780.2911.3312.89
Price To Earnings Ratio97.6797.67-------
Price To Sales Ratio9.697.8114.6710.86575.19375.5839,471.446,453.252,035.62
Gross Margin82.7483.6688.2293.7771.9988.19-146.05-85.5342.11
Operating Margin21.4820.0112.748.83-6,924.20-5,154.28-179,996.05-112,009.87-114,736.84
Net Margin11.8172.567.115.42-7,121.54-5,204.08-183,803.29-113,730.92-114,132.89
Shares Outstanding151.16155.31155.84151.42146.39143.25140.58109.3883.87
Market Capitalization10,065.8210,065.8223,427.5812,930.418,596.9813,579.5835,844.385,525.661,699.39

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue259.94240.34204.92192.57161.71141.15120.86108.19
Cost of Goods Sold Incl. D&A42.0841.1933.5138.1428.0918.9415.5415.46
Gross Profit217.86199.14171.41154.43133.62122.21105.3192.72
Selling, General and Administrative Excl. Other131.96177.47136.61103.94104.2587.3796.6962.77
Research and Development51.2995.3448.4041.1940.8831.7846.3623.87
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income85.9021.6734.8050.4929.3634.848.6229.95
Interest Expense15.8216.577.676.536.726.726.767.06
Unusual Expense-1.371.2310.690.43-0.420.180.100.50
Net Income Before Taxes73.8610.2320.3645.0925.9130.925.4725.45
Income Taxes18.402.450.5922.06-364.992.730.412.12
Consolidated Net Income55.467.7819.7823.04390.8928.195.0623.33
Net Income From Continuing Operations55.467.7819.7823.04390.8928.195.0623.33
Net Income55.467.7819.7823.04390.8928.195.0623.33
EPS (Recurring)0.350.050.170.152.430.170.030.15
EPS (Basic, Before Extraordinaries)0.390.050.140.162.690.190.030.16
EPS (Diluted)0.360.050.120.142.430.170.030.15
EBITDA86.0221.7734.8850.9929.8635.339.1330.01
Non-Operating Income (Expense)2.416.363.921.562.852.973.713.06
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense19.5222.0215.7612.3713.9712.9311.839.44
Price To Earnings Ratio97.6719.1511.9610.7396.54737.501,412.25-
Price To Sales Ratio9.6910.817.597.7110.9312.8816.6114.66
Gross Margin83.8182.8683.6580.1982.6386.5887.1485.71
Operating Margin33.059.0216.9826.2218.1624.697.1327.68
Net Margin21.343.249.6511.96241.7319.974.1921.56
Shares Outstanding151.16153.08153.09155.31155.21158.03158.17155.84
Market Capitalization10,065.828,410.435,304.844,732.615,731.8128,567.9630,966.5523,427.58

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments141.97311.00217.51161.68314.76605.43140.4468.8184.72
Short Term Receivables305.63129.1951.090.001.390.000.000.100.11
Inventories125.59110.4639.820.000.000.000.000.000.00
Other Current Assets57.5815.729.526.6014.816.318.7210.138.49
Total Current Assets630.76566.36317.94168.27330.96611.74149.1579.0393.32
Net Property, Plant & Equipment6.287.158.149.209.239.799.680.250.25
Total Investments and Advances60.482.111.2813.6836.801.261.251.240.59
Intangible Assets--0.800.800.800.800.800.800.80
Deferred Tax Assets348.00--------
Other Assets17.732.071.421.631.842.052.132.292.43
Total Assets1,063.25577.69329.59193.57379.63625.64163.0183.6297.38
Short Term Debt Incl. Current Port. of LT Debt1.041.161.451.582.4124.791.810.070.13
Accounts Payable107.5158.3038.4742.0251.2937.0130.0436.3825.88
Other Current Liabilities45.2131.2313.809.6011.6825.7552.602.411.95
Total Current Liabilities153.7690.6853.7253.2065.3887.5584.4538.8527.96
Long Term Debt252.67252.56109.3581.4876.6418.1339.190.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities8.8112.096.020.300.460.610.7620.732.43
Total Liabilities415.23355.33169.09134.99142.48106.29124.4059.5830.39
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity648.02222.36160.5058.59237.15519.3538.6224.0466.99
Total Shareholders Equity648.02222.36160.5058.59237.15519.3538.6224.0466.99
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity648.02222.36160.5058.59237.15519.3538.6224.0466.99
Total Liabilities & Stockholders Equity1,063.25577.69329.59193.57379.63625.64163.0183.6297.38
Book Value Per Share4.171.431.060.401.663.690.350.290.92
Tangible Book Value Per Share4.171.431.050.391.653.690.350.280.91
Full-Time Employees39933826422628627213410575
Price to Book Ratio17.37122.0178.5085.5757.3870.40157.2171.5336.42
Return on Assets54.505.154.84-69.20-69.26-70.85-140.19-191.70-155.72
Return on Equity102.7512.2111.57-134.13-92.03-100.14-551.85-381.16-230.36
Return on Invested Capital49.654.924.70-141.60-110.94-51.98-222.19-721.76-176.85
Quick Ratio3.295.035.183.165.066.991.772.033.34
Current Ratio4.106.255.923.165.066.991.772.033.34

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income106.06447.1823.3812.67-198.34-348.10-279.38-172.87-173.48
Depreciation0.791.990.280.420.520.490.370.280.09
Other Funds (Non Cash)104.3868.5945.1240.1523.3064.1984.2614.5916.71
Funds from Operations244.48169.7668.7853.25-174.52-283.42-194.75-158.00-156.69
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-158.22-194.54-109.30-84.66-1.65-12.22-19.7625.1927.76
Cash from Operating Activities86.26-24.77-40.52-31.41-176.17-295.63-214.51-132.81-128.93
Capital Expenditures-0.69-0.21-0.040.00-0.01-0.40-0.36-0.13-0.09
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments-22.4514.01-0.99-50.65-20.000.07-24.15-0.591.27
Purchase of Investments-96.45-223.49-311.89-146.88-107.27-55.53-67.40-29.84-31.23
Sale Or Maturity of Investments74.00237.50310.9096.2387.2855.6043.2529.2532.50
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-23.1413.80-1.04-50.65-20.01-0.33-24.51-0.721.18
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-197.83-89.73-7.8547.830.582.44679.83175.02113.64
Repurchase of Common Pref Stock-199.99-91.24-8.760.000.000.000.000.000.00
Sale of Common Pref Stock2.161.510.9147.830.582.44679.83175.02113.64
Proceedsfrom Stock Options0.000.000.0046.300.002.22679.68175.02113.64
Issuance or Reduction of Debt, Net490.060.00136.3724.88-0.9738.980.0029.190.00
Change in Long Term Debt490.060.00136.3724.88-0.9738.980.0029.190.00
Issuance of Long Term Debt745.060.00243.9324.880.0068.980.0029.190.00
Reduction of Long Term Debt-255.000.00-107.550.00-0.97-30.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities292.23-89.73128.5372.70-0.3941.42679.83204.21113.64
Net Change in Cash355.34-100.7086.97-9.36-196.57-254.55440.8170.69-14.11
Free Cash Flow85.56-24.99-40.56-31.41-176.18-296.04-214.86-132.94-129.01
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow101.65--------
Deferred Taxes & Investment Tax Credit--348.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments504.67552.25514.43141.97131.58251.87
Short Term Receivables416.82401.56392.05305.63265.38231.52
Inventories194.32147.97129.03125.59146.95155.20
Other Current Assets55.6443.9051.4657.5855.8525.37
Total Current Assets1,171.451,145.691,086.97630.76599.76663.96
Net Property, Plant & Equipment6.837.086.486.286.506.72
Total Investments and Advances57.4165.7362.8960.4850.0929.91
Deferred Tax Assets333.38343.43344.14348.00366.63-
Other Assets23.1877.7028.3617.732.042.03
Total Assets1,592.251,639.631,528.841,063.251,025.02702.61
Short Term Debt Incl. Current Port. of LT Debt1.841.911.821.041.071.09
Accounts Payable176.86213.69148.84107.51112.34134.02
Other Current Liabilities81.8252.8936.4445.2143.4136.78
Total Current Liabilities260.53268.49187.11153.76156.81171.89
Long Term Debt752.53752.53751.74252.67252.65252.62
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities7.0714.536.868.818.351.67
Total Liabilities1,020.121,035.55945.71415.23417.81426.18
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity572.13604.08583.13648.02607.22276.43
Total Shareholders Equity572.13604.08583.13648.02607.22276.43
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity572.13604.08583.13648.02607.22276.43
Total Liabilities & Stockholders Equity1,592.251,639.631,528.841,063.251,025.02702.61
Book Value Per Share3.783.953.814.173.911.75
Tangible Book Value Per Share3.783.953.814.173.911.75
Full-Time Employees---399374-
Price to Book Ratio17.3714.427.967.6220.65119.95
Return on Assets8.1037.7042.2754.5055.5510.95
Return on Equity17.99100.28112.60102.75111.9626.63
Return on Invested Capital4.190.571.482.5645.465.33
Quick Ratio3.753.725.123.292.892.96
Current Ratio4.504.275.814.103.823.86

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income55.467.7819.7823.04390.8928.19
Depreciation0.120.100.080.500.490.49
Other Funds (Non Cash)26.5927.6128.1522.0416.8015.50
Funds from Operations92.2136.1951.8764.2041.5644.18
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-46.993.07-69.76-44.54-64.71-36.74
Income Taxes Payable2.48-6.13-6.72---
Cash from Operating Activities45.2339.26-17.8919.66-23.157.44
Capital Expenditures-0.28-0.29-0.05-0.07-0.08-0.04
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments1.611.32-9.81-15.5746.44-3.95
Purchase of Investments-13.39-16.43-21.06-45.57-31.31-53.30
Sale Or Maturity of Investments15.0017.7511.2530.0077.7549.35
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities1.331.03-9.86-15.6446.36-3.99
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-99.750.09-99.231.06-78.24-6.44
Repurchase of Common Pref Stock-100.000.00-99.990.00-78.24-6.88
Sale of Common Pref Stock0.250.090.761.060.000.43
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.00490.060.000.000.00
Change in Long Term Debt0.000.00490.060.000.000.00
Issuance of Long Term Debt0.000.00745.060.000.000.00
Reduction of Long Term Debt0.000.00-255.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-99.750.09390.831.06-78.24-6.44
Net Change in Cash-53.1940.38363.075.08-55.03-3.00
Free Cash Flow44.9538.97-17.9519.59-23.237.39
Price to Free Cash Flow101.65497.04----

Revenue breakdown

License2024: 152.00K 2025: 152.00K
Milestone2024: 12.50M
Other2024: 1.82M 2025: 3.59M
Product2024: 313.73M 2025: 606.93M
Royalty2024: 801.00K 2025: 5.62M
United States2024: 329.00M 2025: 616.29M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3020.31%28.8M141.6M1.88M
2026-10-1520.89%29.6M141.6M1.98M
2026-09-3021.63%30.6M141.6M2.05M
2026-09-1521.29%30.2M141.6M2.31M
2026-08-3121.27%30.1M141.6M2.45M
2026-08-1421.26%30.1M141.6M2.37M
2026-07-3120.70%29.3M141.6M2.44M
2026-07-1521.66%30.7M141.7M2.41M
2026-06-3021.30%30.2M141.7M2.34M
2026-06-1521.34%30.2M141.6M2.18M
2026-05-2919.83%28.2M142.1M2.03M
2026-05-1519.79%28.1M142.0M2.10M
2026-04-3019.03%27.0M142.0M1.89M
2026-04-1519.39%28.7M148.1M1.84M
2026-03-3119.55%28.9M148.1M2.13M
2026-03-1319.01%28.1M148.1M1.88M
2026-02-2718.59%27.5M148.1M1.83M
2026-02-1319.91%29.3M147.2M1.86M
2026-01-3019.67%28.9M147.2M2.03M
2026-01-1518.54%27.3M147.2M2.00M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call20.0043.9047.8020.806.6453.000.000.996-0.0250.001
call22.0041.9045.800.006.1550.000.000.995-0.0250.001
call23.0040.9044.900.005.9280.000.000.995-0.0250.001
call24.0039.9043.900.005.7140.000.000.995-0.0250.001
call25.0038.9042.9028.655.5093.000.000.995-0.0250.002
call26.0037.9041.900.005.3130.000.000.995-0.0250.002
call27.0036.9040.9016.205.1268.000.000.994-0.0250.002
call28.0035.9039.9027.584.9471.000.000.994-0.0250.002
call29.0034.9038.9027.504.77421.000.000.994-0.0250.002
call30.0033.8037.9024.004.6083410.000.994-0.0260.002
call31.0032.8036.900.004.4480.000.000.993-0.0260.002
call32.0031.8035.9016.054.2931.000.000.993-0.0260.002
call33.0030.9034.9026.004.1435.000.000.993-0.0260.002
call34.0029.9033.9022.053.9984.000.000.993-0.0260.002
call35.0028.9032.9019.593.85815.000.000.992-0.0260.002
call36.0027.7031.9019.603.72115.000.000.992-0.0250.002
call37.0026.7030.9017.303.58822.000.000.992-0.0250.002
call38.0025.8029.9012.303.4595.000.000.991-0.0250.002
call39.0024.8028.9015.703.3334.000.000.991-0.0250.002
call40.0023.9027.4023.482.9311218.000.991-0.0250.003
call41.0022.9026.9016.203.0899.000.000.973-0.0660.006
call42.0021.8025.9021.302.97222.008.000.971-0.0660.007
call43.0020.8024.9017.002.85722.000.000.970-0.0650.007
call44.0020.0023.3020.472.44225710.000.969-0.0650.007
call45.0019.0021.6021.291.9333800.000.967-0.0640.007
call46.0018.0021.9016.002.38611.000.000.966-0.0640.008
call47.0017.0019.7010.001.8191490.000.964-0.0630.008
call48.0016.0020.0015.302.22689.000.000.962-0.0620.008
call49.0015.0017.5018.001.5293710.000.960-0.0620.009
call50.0014.0016.9014.051.6649320.000.958-0.0610.009
call55.0010.5011.9010.051.2361,3764.000.926-0.0740.014
call60.006.207.706.301.1281,51226.000.767-0.1640.031
call65.002.653.002.650.6831,82664.000.569-0.1550.040
call70.000.701.450.800.7911,94660.000.344-0.1830.038
call75.000.000.400.250.6861,4321730.121-0.0810.021
call80.000.050.950.100.7361,32429.000.050-0.0440.011
call85.000.000.100.100.8502,5420.000.031-0.0350.007
put20.000.002.150.953.2092.000.00-0.004-0.0230.001
put22.000.002.150.952.9641.000.00-0.005-0.0230.001
put23.000.002.150.522.8501.000.00-0.005-0.0230.001
put24.000.002.150.662.74110.000.00-0.005-0.0230.001
put25.000.002.150.212.63616.000.00-0.005-0.0230.002
put26.000.002.150.252.5352.000.00-0.005-0.0230.002
put27.000.002.151.152.4391.000.00-0.006-0.0220.002
put28.000.002.150.202.3462.000.00-0.006-0.0220.002
put29.000.002.150.102.2567.000.00-0.006-0.0220.002
put30.000.001.550.062.1701,1680.00-0.006-0.0220.002
put31.000.002.150.002.0860.000.00-0.007-0.0220.002
put32.000.002.150.002.0050.000.00-0.007-0.0220.002
put33.000.002.150.051.92637.000.00-0.007-0.0220.002
put34.000.001.550.331.8495.000.00-0.007-0.0220.002
put35.000.001.550.451.77571.000.00-0.008-0.0220.002
put36.000.001.900.151.70347.000.00-0.008-0.0210.002
put37.000.002.150.051.63334.000.00-0.008-0.0210.002
put38.000.002.150.221.56420.000.00-0.009-0.0210.002
put39.000.000.950.201.49792.000.00-0.009-0.0210.002
put40.000.000.050.301.4936510.00-0.017-0.0350.004
put41.000.000.950.901.70135.000.00-0.027-0.0620.006
put42.000.000.950.451.62642.000.00-0.029-0.0610.007
put43.000.000.950.201.55350.000.00-0.030-0.0610.007
put44.000.001.350.251.41310.000.00-0.040-0.0670.009
put45.000.000.400.041.4104111.00-0.033-0.0590.007
put46.000.000.851.141.34143.000.00-0.034-0.0590.008
put47.000.002.150.621.27366.000.00-0.036-0.0580.008
put48.000.002.150.101.2063591.00-0.038-0.0570.008
put49.000.000.650.101.14070.000.00-0.040-0.0560.009
put50.000.100.200.151.0501,0364.00-0.043-0.0550.009
put55.000.150.750.200.83786626.00-0.074-0.0680.014
put60.000.001.300.500.88812892.00-0.233-0.1580.031
put65.001.502.202.100.6524367.00-0.431-0.1480.040
put70.004.207.000.001.0980.000.00-0.656-0.1750.038
put75.007.4011.5019.551.3330.000.00-0.879-0.0720.021
put80.0012.3016.4017.801.60540.000.00-0.950-0.0350.011
put85.0017.6021.200.001.8010.000.00-0.969-0.0250.007

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-10-27SCHEDULE 13G/ASEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-11SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-11SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-11SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-11SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-11SEC
2026-06-128-KCurrent report2026-06-11SEC
2026-06-038-KCurrent report2026-06-03SEC
2026-05-278-KCurrent report2026-05-27SEC
2026-05-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-068-KCurrent report2026-05-06SEC
2026-04-30DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-11SEC
2026-04-29SCHEDULE 13GSEC
2026-03-27SCHEDULE 13G/ASEC
2026-03-208-KCurrent report2026-03-18SEC
2026-02-2710-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-268-KCurrent report2026-02-26SEC
2026-01-294Statement of changes in beneficial ownership of securities2026-01-28SEC
2026-01-138-KCurrent report2026-01-13SEC
2026-01-094Statement of changes in beneficial ownership of securities2026-01-08SEC
2026-01-094Statement of changes in beneficial ownership of securities2026-01-08SEC
2025-11-254Statement of changes in beneficial ownership of securities2025-11-24SEC
2025-11-24144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-0900274.80K1
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-1100162.85K1

Institutional holders

Manager% owned
BlackRock, Inc.14.40%
VANGUARD PORTFOLIO MANAGEMENT LLC5.20%
STATE STREET CORP5.09%
VANGUARD CAPITAL MANAGEMENT LLC4.02%
GEODE CAPITAL MANAGEMENT, LLC2.42%
D. E. Shaw & Co., Inc.2.22%
Soleus Capital Management, L.P.1.91%
PRICE T ROWE ASSOCIATES INC /MD/1.81%
Clearbridge Investments, LLC1.73%
CONGRESS ASSET MANAGEMENT CO1.70%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF5.19%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.86%
iShares Russell 2000 ETF2.44%
VANGUARD SMALL-CAP INDEX FUND2.06%
State Street(R) SPDR(R) S&P(R) Biotech ETF1.40%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.19%
Fidelity Small Cap Index Fund1.04%
VANGUARD EXTENDED MARKET INDEX FUND0.99%
iShares Russell 2000 Growth ETF0.88%
Congress Small Cap Growth Fund0.85%

OakChart. TGTX. Cached 15 minutes.